BMC Cancer BioMed Central Open Access

First Page		Document Content
Metastatic liver disease Adjuvant therapy Cetuximab Bevacizumab Colorectal cancer Hepatectomy Oxaliplatin Capecitabine Metastasectomy Medicine Hepatology Surgical oncology		BMC Cancer BioMed Central Open Access Add to Reading List Source URL: www.biomedcentral.com Download Document from Source Website File Size: 268,90 KB Share Document on Facebook

	Stuttgart Research Center Systems Biology (SRCSB) Systems Biology Seminar Talk „Heterogeneity and druginduced plasticity in colorectal cancer“ DocID: 1voOg - View Document
	Histopathology 2007, 50, 113–130. DOI: j02549.x REVIEW Classification of colorectal cancer based on correlation of clinical, morphological and molecular features DocID: 1vkot - View Document
	TUESDAY POSTER PRESENTATION TP01 - Cancer, Clinical and Translational Proteomics MO01-001 Verification of colorectal cancer biomarker candidates in plasma/serum extracellular vesicles by targeted proteomics Takeshi Tomon DocID: 1v6qe - View Document
	License Agreement to Develop Colorectal Cancer Risk Assessment Test DocID: 1v4r9 - View Document
	UNIVERSITY HOSPITAL & CLINICS COLORECTAL CANCER IN ACADIANA 2017 PHYSICIAN STUDY Overview: Colorectal cancer is the third leading type of cancer diagnosed in the U.S. There was an estimated 135,430 cases inColorec DocID: 1uS1a - View Document